K. Fred Gey

Q: What Schools Are Affiliated With K. Fred Gey

K. Fred Gey is affiliated with the following schools: University of Basel, University of Tübingen

K. Fred Gey's AcademicInfluence.com Rankings

K. Fred Gey

Philosophy

#8418

World Rank

#11798

Historical Rank

Logic

#5456

World Rank

#6860

Historical Rank

philosophy Degrees

Download Badge

Philosophy

K. Fred Gey's Degrees

PhD Library and Information Science University of California, Berkeley

Why Is K. Fred Gey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

K. Fred Gey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene (1991) (785)
Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. (1991) (684)
Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. (1987) (433)
The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. (1996) (334)
Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. (1993) (315)
The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms. (1990) (291)
Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology (1989) (258)
Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. (1993) (252)
Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. (1998) (229)
Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. (1991) (216)
Prediction of male cancer mortality by plasma levels of interacting vitamins: 17‐year follow‐up of the prospective Basel study (1996) (201)
Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers (1991) (170)
Benzoquinolizine Derivatives: a New Class of Monamine Decreasing Drugs With Psychotropic Action (1962) (163)
Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study (2004) (159)
Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: Threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk (1995) (157)
Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. (1989) (150)
Plasma homocysteine and cardiovascular disease mortality (1997) (147)
CHLORINATED ARYLALKYLAMINES AFFECTING THE CEREBRAL METABOLISM OF 5-HYDROXYTRYPTAMINE. (1964) (125)
Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. (1998) (125)
On the antioxidant hypothesis with regard to arteriosclerosis. (1986) (112)
Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. (1992) (108)
Beta-carotene and cancer prevention: the Basel Study. (1991) (100)
Metabolic effects of nicotinic acid and its derivatives (1971) (98)
Relationship of Plasma Level of Vitamin C to Mortality from Ischemic Heart Disease (1987) (90)
Influence of chlorpromazine and chlorprothixene on the cerebral metabolism of 5-hydroxytryptamine, norepinephrine and dopamine. (1961) (87)
INHIBITION OF DECARBOXYLASE OF AROMATIC AMINO ACIDS BY 2,3,4-TRIHYDROXYBENZYLHYDRAZINE AND ITS SERYL DERIVATIVE. (1964) (83)
Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. (1995) (79)
Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. (1990) (79)
Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke respectively: 12-year follow-up of the Prospective Basel Study. (1992) (77)
Variation of the norepinephrine metabolism of the rat heart with age. (1965) (70)
The effect of a new decarboxylase inhibitor on endogenous and exogenous monoamines (1963) (70)
Photometric "titration" of free fatty acids with the Technicon AutoAnalyzer. (1966) (68)
DIAMINE OXIDASE IN THE BRAIN OF VERTEBRATES * (1963) (68)
Depletion of plasma vitamin C but not of vitamin E in response to cardiac operations. (1994) (67)
DECREASE OF CEREBRAL 5-HYDROXYTRYPTAMINE AND 5-HYDROXYINDOLACETIC ACID BY AN ARYLALKYLAMINE. (1963) (59)
The concentration of glucose in rat tissues. (1956) (58)
Inhibitors of monoamine oxidase and decarboxylase of aromatic amino acids (1966) (55)
Tenth Annual Meeting of the European Association for the Study of Diabetes (1974) (53)
Liberation of p-hydroxynorephedrine from cat spleen by sympathetic nerve stimulation after pretreatment with amphetamine. (1966) (52)
Two sites of 5-hydroxytryptamine uptake in blood platelets. (1967) (49)
Depression of Norepinephrine and 5-Hydroxytryptamine in the Brain by Benzoquinolizine Derivatives (1959) (48)
Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitter. (1965) (45)
ACTIVITY OF MONOAMINE OXIDASE IN RELATION TO THE 5‐HYDROXYTRYPTAMINE AND NOREPINEPHRINE CONTENT OF THE RAT BRAIN * (1961) (44)
Low plasma retinol predicts coronary events in healthy middle-aged men: the PRIME Study. (2010) (43)
Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy. (1989) (43)
Distribution and metabolism of DL-3,4-dihydroxy[2-14C]-phenylalanine in rat tissues. (1964) (39)
Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. (1999) (39)
Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. (2000) (38)
Quantitative aspects of the replacement of norepinephrine by dopamine as a sympathetic transmitter after inhibition of dopamine-beta-hydroxylase by disulfiram. (1967) (36)
SUPPRESSION OF GLYCOLYSIS IN RAT BRAIN IN VIVO CHLORPROMAZINE, RESERPINE, AND PHENOBARBITAL. (1965) (36)
Cardiovascular disease and vitamins. Concurrent correction of 'suboptimal' plasma antioxidant levels may, as important part of 'optimal' nutrition, help to prevent early stages of cardiovascular disease and cancer, respectively. (1995) (35)
EFFECT OF MONOAMINE RELEASERS AND DECARBOXYLASE INHIBITORS ON ENDOGENOUS 5-HYDROXYINDOLE DERIVATIVES IN BRAIN. (1964) (34)
Prevention of cholesteryl ester accumulation in P388D1 macrophage-like cells by increased cellular vitamin E depends on species of extracellular cholesterol. Conventional heterologous non-human cell cultures are poor models of human atherosclerotic foam cell formation. (1995) (34)
Supplementation with antioxidants prior to bone marrow transplantation. (1997) (31)
INHIBITION OF THE HYDROXYLATION OF TRYPTOPHAN AND PHENYLALANINE BY ALPHA-METHYL-DOPA AND SIMILAR COMPOUNDS. (1964) (28)
Differential Effects of Cigarette Smoking and Alcohol Consumption on the Plasma Levels of Carotenoids in Middle‐aged Japanese Men (1996) (27)
Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen (2004) (26)
EFFECT OF INHIBITORS OF MONOAMINE OXIDASE ON VARIOUS ENZYMES AND ON THE STORAGE OF MONOAMINES (1963) (25)
Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial. (1999) (24)
Nutritional factors correlating with cardiovascular disease: results of the Basel Study. (1992) (24)
Differentiation of monoamine oxidase and diamine oxidase. (1962) (23)
Anti-oxidants and pro-oxidants in coronary heart disease (1991) (21)
Cancer Mortality and Vitamin E Status (1989) (21)
AMINO ACID AND FATTY ACID HYDRAZIDES: CHEMISTRY AND ACTION ON MONOAMINE OXIDASE (1959) (21)
Inhibition of diamine oxidase in vivo by hydrazine derivatives. (1960) (20)
Optimum plasma levels of antioxidant micronutrients. Ten years of antioxidant hypothesis on arteriosclerosis. (1994) (18)
A new inhibitor of decarboxylase of aromatic amino acids (1962) (17)
EFFECTS OF CHLORPROMAZINE ON THE METABOLISM OF DL-2-C14-DOPA IN THE RAT. (1964) (17)
EFFECT OF NEUROTROPIC AGENTS ON TOTAL PYRIDOXAL PHOSPHATE AND ON THE ACTIVITY OF THE DECARBOXYLASE OF AROMATIC AMINO ACIDS AS WELL AS OF OTHER PYRIDOXAL PHOSPHATE‐DEPENDENT ENZYMES IN RAT BRAIN 1 (1974) (17)
Concurrent quantification of cellular cholesterol, cholesteryl esters and triglycerides in small biological samples. Reevaluation of thin layer chromatography using laser densitometry. (1997) (17)
Influence of chlorpromazine on decarboxylases of aromatic amino acids. (1961) (16)
Interference of Chlorpromazine with the Metabolism of Aromatic Amino-acids in Rat Brain (1962) (15)
THE UPTAKE OF TRYPTAMINE BY BRAIN IN VIVO AND ITS ALTERATION BY DRUGS. (1963) (15)
Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial (2010) (14)
[Biochemical bases for the treatment of Parkinson's syndrome with L-dopa]. (1970) (13)
Cardiovascular Disease and Vitamins (1995) (13)
Diminished effect of sympathetic nerve stimulation in cats pretreated with 5-hydroxydopa; formation and liberation of false adrenergic transmitters (2004) (12)
Action of imipramine and amitriptyline on cerebral monoamines as compared with chlorpromazine. (1962) (12)
The effect of α-methyl-tyrosine on peripheral sympathetic transmission (1966) (12)
Modelling of mortality data from a multi-centre study in Japan by means of Poisson regression with error in variables. (1997) (12)
[Antioxidant vitamins and disease--risk of a suboptimal supply]. (1994) (11)
[Vitamins during high dose chemo- and radiotherapy]. (1992) (10)
Stereospecificity of monoamine oxidase inhibitors. (1958) (9)
Epidemiological Correlations between Poor Plasma Levels of Essential Antioxidants and the Risk of Coronary Heart Disease and Cancer (1992) (9)
Species differences in the action of monoamine oxidase inhibitors. (1961) (9)
[Changes in vitamin C content of Bintje potatoes during storage and usual culinary preparations]. (1983) (9)
Diminution of 5-hydroxytryptamine in thrombocytesin vitro by chlorpromazine and related compounds (1961) (8)
Inverse correlation of vitamin E and ischemic heart disease. (1989) (8)
Cancer Mortality Inversely Related to Plasma Levels of Antioxidant Vitamins (1987) (8)
CHLORPROMAZINE‐INDUCED ACCUMULATION OF PYRIDOXAL‐5′‐PHOSPHATE AND ACTIVATION OF THE DECARBOXYLASE OF AROMATIC AMINO ACIDS IN RAT BRAIN (1969) (7)
Association of low plasma antioxidant levels with all-cause mortality and coronary events in healthy middle-aged men from France and Northern Ireland in the PRIME study (2020) (7)
Acceleration of turnover of14C-catecholamines in rat brain by chlorpromazine (1968) (7)
Plasma vitamin E, apolipoprotein B and HDL-cholesterol in middle-aged men from southern Italy. (1989) (7)
[Determination of fatty acid esters in blood and organ lipids]. (1956) (7)
Increase of gingival hydroxyproline and proline by improvement of ascorbic acid status in man. (1986) (7)
The effect of 2-hydroxy-benzoquinolizines on cerebral 5-hydroxytryptamine, spontaneous locomotor activity, and ethanol hypnosis in mice. (1962) (6)
Accumulation of Exogenous Monoamines in Brain in vivo and its Alteration by Drugs (1964) (6)
[Monoamine oxidase inhibitors]. (1960) (6)
Prediction of increased cancer risk in humans by interacting suboptimal plasma levels of retinol and carotene. (1994) (6)
Increase of pyruvic and lactic acid in rat blood by inhibitors of monoamine oxidase (1961) (5)
Effect of chlorpromazine on the penetration of monoamine oxidase inhibitors and monoamine releasers into rat brain. (1963) (5)
Effect of psychotropic drugs on decar☐ylase of aromatic amino acids in rat brain (1962) (5)
Influence of chlorpromazine and chlorprothixene on the cerebral metabolism of monoamines. (1961) (5)
EFFECT OF α‐ALKYLATED TRYPTAMINE DERIVATIVES ON 5‐HYDROXYTRYPTAMINE METABOLISM IN VIVO (1962) (5)
Decrease of Alpha‐Tocopherol and Beta‐Carotene by High‐Dose Radiochemotherapy Preceding Bone Marrow Transplantation (1989) (5)
Decrease of norepinephrine in brain and heart of vitamin E deficient rats (1968) (4)
Hemmung der Cholinoxydase in vivo durch Neuropharmaca (1963) (4)
Inverse correlation between the plasma level of antioxidant vitamins and the incidence of ischemic heart disease (IHD) in cross-sectional epidemiology (1987) (4)
Vitamin B6 status, MTHFR and hyperhomocysteinaemia. (1997) (4)
271 Interference with the permeation of aromatic monoamines and amino-acids in brain, a possible new type of drug action (1961) (3)
[Nutritional and physiological significance of fats]. (1971) (3)
Enhancement of tyrosine transamination in vivo by catecholamines (1970) (3)
Cyclic adenosine 3',5'-monophosphate and adenylcyclase in liver, adipose tissue and brain of rats treated with β-pyridylcarbinol (1971) (3)
[INHIBITION OF TRYPTOPHAN HYDROXYLASE BY ALPHA-METHYLDOPA]. (1964) (2)
Thiol and cardiovascular risk factor status in a male northern Irish population. (2008) (2)
Contents, Vol. 8, 1963 (1963) (2)
Liberation of α-methyldopamine as a “false” sympathetic transmitter after pretreatment of cats with α-methyldopa and disulfiram (2004) (2)
[The effect of chlorpromazine on the pharmacological changes of 5-hydroxytryptamine- and noradrenalin content in the brain]. (1960) (2)
Topographical differences in the cerebral metabolism ofDL-2-14C-3,4-Dihydroxyphenylalanine (1962) (2)
Monoamine oxidase inhibitors and the extrapyramidal system. (1976) (2)
Post mortem increase of 5-hydroxytryptamine in rat brain after 5-hydroxytryptophan administration (1960) (1)
Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram. (1967) (1)
PHARMACOLOGICAL INFLUNCE ON THE CENTRAL NERVOUS SYSTEM BY BRIEFACTING MONOAMINE OXIDASE (MAO) INHIBITORS OF THE HARMALA ALKALOID GROUP (1959) (1)
Lipid peroxidation : its mechanism, measurement, and significance. Discussion (1993) (1)
[Essential antioxidants in cardiovascular diseases--lessons for Europe]. (1994) (1)
Inhibition of Tryptophan and Phenylalanine Hydroxylase by α-Methyldopa, α, β, β-Trimethyldopa, and Other Compounds (1965) (1)
[The replacement of noradrenaline by dopamine as a postganglionic sympathetic transmitter in the inhibition of dopamine beta-hydroxylase by disulfiram]. (1966) (1)
[Effect of chlorpromazine and chlorprothixen on monoamine metabolism in the rat brain]. (1961) (0)
[Influence of alkyl-hydrazides of amino acids on monoamine metabolism in vivo]. (1958) (0)
[On the biochemistry of drugs influencing the monoamine metabolism in the brain]. (1960) (0)
Cyclic adenosine 3',5'-monophosphate and enylcyclase in liver, adipose tissue and brain of rats treated with beta-pyridylcarbinol. (1971) (0)
The effect of a new decarboxylase inhibitor on endogenous monoamines. (1963) (0)
[Quantitative determination of citric acid in the blood and urine by the formation of pentabromoacetone]. (1953) (0)
[DOPA-DOPP-transaminases of rat brain in vitro]. (1967) (0)
[Plasma vitamin A and E correlate inversely with coronary mortality]. (1989) (0)
[An increase of serum lactic acid by monoamine oxidase inhibitor]. (1960) (0)
[Mechanism of action of hypoglycemic sulfonylureas]. (1957) (0)
THE EFFECT OF PSYCHOTROPIC DRUGS ON THE METABOLISM OF EXOGENOUS DL-2-C14-3,4-DIHYDROXYPHENYLALANINE. (1964) (0)
Has high-dose vitamin E supplementation a protective effect during open heart surgery? (1990) (0)
Quantitative estimation of citric acid in blood and urine by conversion to pentabromoacetone. (1953) (0)
Contents, Vol. 13, 1965 (1965) (0)
[Age conditioned changes in catecholamine metabolism in the rat heart]. (1966) (0)
[Decrease of lipid infiltration of the rat liver by beta-pyridyl-carbinol]. (1966) (0)
Index rerum ad Vol. 13 (1965) (0)
[Biochemical problems of the origin of arteriosclerosis]. (1969) (0)
Conclusions and General Summary (1960) (0)
Decrease of plasma cholesterol in rats by glucagon. (1973) (0)
Antioxidant systems: actions and interactions (1997) (0)
Contents, Vol. 37(Suppl. 2), 1960 (1960) (0)
[Cholesterol binding capacity of the blood serum in hypertension]. (1957) (0)
[ALPHA,BETA,BETA-TRIMETHYLDOPA, A NEW INHIBITOR OF TRYPTOPHAN AND PHENYLALANINE HYDROXYLASE]. (1964) (0)
The effect of alpha-methyl-tyrosine on peripheral sympathetic transmission. (1966) (0)
[INHIBITION OF CHOLINE OXIDASE IN VIVO BY NEUROPHARMACOLOGICAL AGENTS]. (1963) (0)
Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo. (1962) (0)
[Biological distribution of a benzoquinolizine derivative and its effect on the 5-hydroxytryptamine and noradrenalin content of the tissue]. (1960) (0)
[CHANGES IN THE CATECHOLAMINE METABOLISM IN THE RAT HEART CAUSED BY OLD AGE]. (1964) (0)
[Neuroleptics as activators of tyrosine hydroxylation in vivo]. (1966) (0)
Low antioxidant vitamins in plasma of cases with subsequent stomach cancer (1988) (0)
[Effect of hypoglycemic sulfonylureas on isolated rat diaphragm]. (1957) (0)
[The influence of DOPA-transamination on DOPA-decarboxylation in vitro]. (1964) (0)
Vitamin E: the Functional Significance of Suboptimal Plasma Levels (1991) (0)
[Adenyl cyclase in rat brain]. (1968) (0)
Reply to PB Duell and MR Malinow (1999) (0)
Semi‐, Mono‐, Sesqui‐, and Triterpenes as Cholesterol Precursors (2009) (0)
[Documentation of biochemical literature on marginal punch cards]. (1955) (0)
[Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models]. (1972) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With K. Fred Gey?

K. Fred Gey is affiliated with the following schools: